We further confirmed our findings by subjecting HSC-specific VCAM-1 deficient and control mice to a second model of NASH induction, which is of longer duration as compared to the HCD, while mimicking several aspects of human NASH [24]. This evidence concerns the gene VCAM1 and metabolic dysfunction-associated steatohepatitis.